(Q27853194)

English

Optimal adjuvant treatment for patients with HER2-positive breast cancer in 2015.

scientific article

In more languages

default for all languages

No label defined

No description defined

edit

Statements

2 references

PubMed publication ID

26255196

retrieved

13 November 2016

stated in

Europe PubMed Central

PubMed publication ID

26255196

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26255196%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 February 2020

review article

1 reference

stated in

Europe PubMed Central

title

Optimal adjuvant treatment for patients with HER2-positive breast cancer in 2015 (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26255196

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26255196%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 February 2020

main subject

Her2-receptor positive breast cancer

0 references

author

Tamer M Fouad

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26255196

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26255196%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 February 2020

author name string

Dimitrios Zardavas

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26255196

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26255196%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 February 2020

Martine Piccart

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26255196

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26255196%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 February 2020

language of work or name

English

0 references

publication date

5 August 2015

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26255196

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26255196%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

26255196

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26255196%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 February 2020

volume

24 Suppl 2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26255196

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26255196%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 February 2020

page(s)

S143-8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26255196

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26255196%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 February 2020

Identifiers

DOI

10.1016/J.BREAST.2015.07.034

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26255196

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26255196%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 February 2020

PubMed publication ID

26255196

2 references

stated in

PubMed

PubMed publication ID

26255196

retrieved

13 November 2016

stated in

Europe PubMed Central

PubMed publication ID

26255196

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26255196%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 February 2020

ResearchGate publication ID

280831805

0 references

(Q27853194)

Optimal adjuvant treatment for patients with HER2-positive breast cancer in 2015.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)